Cancer Cell Lines & CDX
Rigorous QC, rapid response, and flexible customization—delivering success for your projects.
Cancer Cell Lines & CDX
Built on our large-scale, diverse cell resource library and advanced screening platforms, we provide end-to-end support for innovative drug development—from target validation to lead candidate screening—across a broad range of modalities, including small molecules, PROTACs, molecular glues, ADCs, bispecific antibodies, and monoclonal antibodies.
Assay Capabilities：
- 2D & 3D Cell Culture Models: Combining traditional monolayer cultures with advanced 3D models—including organoids and spheroids—to better recapitulate the tumor microenvironment and in vivo biological complexity.
- Cell Proliferation & Viability Assays: Utilizing CCK 8 and ATP-based detection to provide multi-time-point, multi-parameter growth inhibition assessment. Supports single-agent and combination therapy evaluation.
- Functional Cell-Based Assays: Phenotypic analysis of migration, invasion, apoptosis, and cell cycle to elucidate compound mechanisms of action.
- Cell Panel Screening: High throughput screening enables parallel testing of compounds across multiple cell lines for rapid identification of active compounds and sensitive cell lines, supporting indication expansion for clinical candidates.
We look forward to partnering with you to accelerate your oncology drug discovery programs through our specialized cell based platforms and deep assay expertise.
Tailored to Your Needs —
Precision Models for Your Research
Not finding what you need? Submit a custom sample request to access models tailored to your specific research requirements.
Reprogramming Cells, Empowering Medicine
©2026 PRECEDO Biotechnology Co., Ltd. Powered by：www.300.cn